1. Food and Drug Administration. FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-interoperable-automated-insulin-dosing-controller-designed-allow-more-choices. Published March 24, 2020. Accessed July 15, 2024.
2. Kelm K. Re: SmartAdjust Technology 510(k) Premarket Notification of Intent to Market the Device. US FDA; 2022. www.accessdata.fda.gov/cdrh_docs/pdf20/K203774.pdf. Accessed July 15, 2024.
3. Insulet Announces FDA 510(k) Clearance of the Omnipod® 5 App for iPhone. https://investors.insulet.com/news/news-details/2023/Insulet-Announces-FDA-510k-Clearance-of-the-Omnipod-5-App-for-iPhone/default.aspx. Accessed July 15, 2024.
4. Federal Register. Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Interoperable Automated Glycemic Controller. https://www.federalregister.gov/documents/2022/03/14/2022-05303/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the. Published March 14, 2022. Accessed July 15, 2024.
5. Food and Drug Administration. FDA Roundup: January 24, 2023.https://www.fda.gov/news-events/press-announcements/fda-roundup-january-24-2023. Published January 24, 2023. Accessed July 15, 2024.